Unknown NA INTERVENTIONAL 2-arm NCT01364675

Primary Prevention of Cardiovascular Disease (CVD) in Pre-diabetic & Pre-hypertensive Subjects (PPCVD)

Primary Prevention of Cardiovascular Disease in Pre-diabetic & Pre-hypertensive Subjects Using Multiple Risks Reduction Strategy: A Multi-center, Double-blind, Randomized Controlled Trial

Sponsor: National Health Security Office, Thailand

Conditions Pre-diabetes Pre-hypertension

Interventions Metformin+Enalapril+Simvastatin Placebo tablet

Updated 5 times since 2017 Last updated: Jun 1, 2011 Started: Jan 31, 2012 Primary completion: Jul 31, 2016 Completion: Dec 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01364675, this NA trial focuses on Pre-diabetes and Pre-hypertension and remains ongoing. Sponsored by National Health Security Office, Thailand, it has been updated 5 times since 2012, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jun 2018 — Jan 2021 [monthly]

Unknown Status NA
Jan 2017 — Jun 2018 [monthly]

Unknown Status NA

First recorded

Jan 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Health Security Office, Thailand
Ramathibodi Hospital
The Government Pharmaceutical Organization
Ubon Ratchathani Public Health Office, Thailand

Data source: Ramathibodi Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Muang District, Thailand